Employment and activity limitations among adults with chronic obstructive pulmonary disease--United States, 2013

Anne G Wheaton, Timothy J Cunningham, Earl S Ford, Janet B Croft, Centers for Disease Control and Prevention (CDC), Anne G Wheaton, Timothy J Cunningham, Earl S Ford, Janet B Croft, Centers for Disease Control and Prevention (CDC)

Abstract

Chronic obstructive pulmonary disease (COPD) is a group of progressive respiratory conditions, including emphysema and chronic bronchitis, characterized by airflow obstruction and symptoms such as shortness of breath, chronic cough, and sputum production. COPD is an important contributor to mortality and disability in the United States. Healthy People 2020 has several COPD-related objectives,* including to reduce activity limitations among adults with COPD. To assess the state-level prevalence of COPD and the association of COPD with various activity limitations among U.S. adults, CDC analyzed data from the 2013 Behavioral Risk Factor Surveillance System (BRFSS). Among U.S. adults in all 50 states, the District of Columbia (DC), and two U.S. territories, 6.4% (an estimated 15.7 million adults) had been told by a physician or other health professional that they have COPD. Adults who reported having COPD were more likely to report being unable to work (24.3% versus 5.3%), having an activity limitation caused by health problems (49.6% versus 16.9%), having difficulty walking or climbing stairs (38.4% versus 11.3%), or using special equipment to manage health problems (22.1% versus 6.7%), compared with adults without COPD. Smokers who have been diagnosed with COPD are encouraged to quit smoking, which can slow the progression of the disease and reduce mobility impairment. In addition, COPD patients should consider participation in a pulmonary rehabilitation program that combines patient education and exercise training to address barriers to physical activity, such as respiratory symptoms and muscle wasting.

Figures

FIGURE 1
FIGURE 1
Age-adjusted prevalence* of chronic obstructive pulmonary disease (COPD)† among adults aged ≥18 years —Behavioral Risk Factor Surveillance System, United States, 2013 * Age-adjusted to the 2000 U.S. standard population aged ≥18 years. † Based on a positive response to the question, “Have you ever been told by a doctor or health professional that you have COPD, emphysema, or chronic bronchitis?”
FIGURE 2
FIGURE 2
Age-adjusted percentage* of adults with chronic obstructive pulmonary disease (COPD)† aged ≥18 years with activity limitations, by smoking§ and physical activity¶ status — Behavioral Risk Factor Surveillance System, United States, 2013 * Age-adjusted to the 2000 U.S. standard population aged ≥18 years. † Based on a positive response to the question, “Have you ever been told by a doctor or health professional that you have COPD, emphysema, or chronic bronchitis?” § Current smokers reported smoking ≥100 cigarettes in their life and currently smoking cigarettes some days or every day. Nonsmokers include former smokers and never smokers. ¶ Respondents were categorized as engaging in physical activity if they answered “yes” to the question, “During the past month, other than your regular job, did you participate in any physical activities or exercises such as running, calisthenics, golf, gardening, or walking for exercise?” ** 95% confidence interval. †† Respondents were categorized as having activity limitations if they answered “yes” to the question, “Are you limited in any way in any activities because of physical, mental, or emotional problems?”

References

    1. Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep. 2013;62:1–96.
    1. US Burden of Disease Collaborators. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591–608.
    1. Lee PN, Fry JS. Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med. 2010;8:84.
    1. Wolinsky FD, Bentler SE, Hockenberry J, et al. Long-term declines in ADLs, IADLs, and mobility among older Medicare beneficiaries. BMC Geriatr. 2011;11:43.
    1. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(Suppl):4S–42S.
    1. Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020. Chest. 2015;147:31–45.
    1. Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis. 2014;9:289–300.
    1. Thornton Snider J, Romley JA, Wong KS, Zhang J, Eber M, Goldman DP. The Disability burden of COPD. COPD. 2012;9:513–21.
    1. Cunningham TJ, Ford ES, Rolle IV, Wheaton AG, Croft JB. Associations of self-reported cigarette smoking with chronic obstructive pulmonary disease and co-morbid chronic conditions in the United States. COPD. 2014 [Epub ahead of print]
    1. Zhang J, Lin XF, Bai CX. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Int J Chron Obstruct Pulmon Dis. 2014;9:57–63.

Source: PubMed

3
Suscribir